These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12000652)

  • 41. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.
    Asonganyi T; Bedifeh BA; Ade SS; Ngu JL
    Afr J Med Med Sci; 1994 Mar; 23(1):39-46. PubMed ID: 7839945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for Trypanosoma brucei gambiense antibodies with the Indirect Fluorescent Antibody Test (IFAT). Effect of age and previous treatment.
    Kegels G; Criel B; van Lerberghe W; Mentens H; Magnus E; Van Balen H
    Ann Soc Belg Med Trop; 1992 Dec; 72(4):271-81. PubMed ID: 1292423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Practical value of complement fixation in Trypanosoma gambiense sleeping sickness. I. Diagnosis].
    SCHOENAERS F; NEUJEAN G; EVENS F
    Ann Soc Belg Med Trop (1920); 1953 Apr; 33(2):140-69. PubMed ID: 13092711
    [No Abstract]   [Full Text] [Related]  

  • 45. Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.
    Simo G; Mansinsa Diabakana P; Kande Betu Ku Mesu V; Manzambi EZ; Ollivier G; Asonganyi T; Cuny G; Grébaut P
    Emerg Infect Dis; 2006 Dec; 12(12):1968-70. PubMed ID: 17326955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Spinal and cerebral fluids in sleeping sickness from Trypanosoma gambiense].
    NEUJEAN G
    Ann Soc Belg Med Trop (1920); 1950 Nov; 30(5):1125-1387. PubMed ID: 14811248
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemotherapy of African sleeping sickness. I. Chemotherapy of experimental Trypanosoma gambiense infection in mice (Mus musculus) with nitrofurazone.
    PACKCHANIAN A
    Am J Trop Med Hyg; 1955 Jul; 4(4):705-11. PubMed ID: 13238726
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of penicillin in sleeping sickness (Trypanosoma gambiense)].
    PIRES FM
    An Inst Med Trop (Lisb); 1951 Mar; 8(1):65-81. PubMed ID: 14894799
    [No Abstract]   [Full Text] [Related]  

  • 49. Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan.
    Maina NW; Oberle M; Otieno C; Kunz C; Maeser P; Ndung'u JM; Brun R
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):540-6. PubMed ID: 17275053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human African trypanosomiasis.
    Kioy D; Jannin J; Mattock N
    Nat Rev Microbiol; 2004 Mar; 2(3):186-7. PubMed ID: 15751187
    [No Abstract]   [Full Text] [Related]  

  • 51. Differentiation of Trypanosoma brucei, T. rhodesiense, and T. gambiense by the indirect fluorescent antibody test.
    Latif BM; Adam KM
    Bull World Health Organ; 1973; 48(4):401-7. PubMed ID: 4587481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The epidemiological importance of the animal reservoir of Trypanosoma brucei gambiense in the Congo. 2. Characterization of the Trypanosoma brucei complex.
    Noireau F; Paindavoine P; Lemesre JL; Toudic A; Pays E; Gouteux JP; Steinert M; Frezil JL
    Trop Med Parasitol; 1989 Mar; 40(1):9-11. PubMed ID: 2740734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Mpia B; Ethier L; Mansinsa D
    Lancet; 1989 Jun; 1(8649):1246-50. PubMed ID: 2566790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.
    Sternberg JM; Maclean L
    Parasitology; 2010 Dec; 137(14):2007-15. PubMed ID: 20663245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire.
    Pepin J; Milord F; Mpia B; Meurice F; Ethier L; DeGroof D; Bruneel H
    Trans R Soc Trop Med Hyg; 1989; 83(4):514-7. PubMed ID: 2694491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The double-edged sword of evolution.
    Kruzel-Davila E; Skorecki K
    Elife; 2017 Jul; 6():. PubMed ID: 28671870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
    Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
    Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon.
    Dukes P; Gibson WC; Gashumba JK; Hudson KM; Bromidge TJ; Kaukus A; Asonganyi T; Magnus E
    Acta Trop; 1992 Jun; 51(2):123-34. PubMed ID: 1354930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of Trypanosoma brucei gambiense in the host and alternative sleeping sickness diagnostic approaches.
    Wery M; Mulumba MP
    Ann Soc Belg Med Trop; 1989; 69 Suppl 1():181-7; discussion 212-4. PubMed ID: 2679454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
    Pépin J; Khonde N
    Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.